All Pharma News
price-trendAsk Us
STALICLA Initiates US DDI Study Of STP7 For Cocaine Use Disorder

STALICLA Initiates US DDI Study Of STP7 For Cocaine Use Disorder
GLOBENEWSWIRE
02 May 2024
Share Share
STALICLA Appoints Dr. Thomas Blaettler, MD

STALICLA Appoints Dr. Thomas Blaettler, MD
BUSINESSWIRE
11 Apr 2024
Share Share
Stalicla Secures $17.4 Million in Series B Financing

Stalicla Secures $17.4 Million in Series B Financing
GLOBENEWSWIRE
16 Jan 2024
Share Share
STALICLA and Firefly enter Partnership Agreement for the Development of EEG

STALICLA and Firefly enter Partnership Agreement for the Development of EEG
GLOBENEWSWIRE
27 Mar 2023
Share Share
STALICLA signs CRADA with US NIDA to cover PIII development of mavoglurant

STALICLA signs CRADA with US NIDA to cover PIII development of mavoglurant
GLOBENEWSWIRE
08 Mar 2023
Share Share
STALICLA signs in-licensing agreement for late-stage clinical neuropsychiatric

STALICLA signs in-licensing agreement for late-stage clinical neuropsychiatric
GLOBENEWSWIRE
09 Jan 2023
Share Share
Stalicla pledges $270M for Novartis` failed fragile X asset

Stalicla pledges $270M for Novartis` failed fragile X asset
James Waldron FIERCE BIOTECH
09 Jan 2023
Share Share
STALICLA to in-license SFX-01 from Evgen for neurodevelopment disorder

STALICLA to in-license SFX-01 from Evgen for neurodevelopment disorder
FIRSTWORLDPHARMA
10 Oct 2022
Share Share
STALICLA Nabs EUR 1.7M to Lead Computational Drug in EU-funded REPO4EU Project

STALICLA Nabs EUR 1.7M to Lead Computational Drug in EU-funded REPO4EU Project
BUSINESSWIRE
19 Jul 2022
Share Share
STALICLA Completes Successful Phase 1b Trials in Autism Spectrum Disorder

STALICLA Completes Successful Phase 1b Trials in Autism Spectrum Disorder
BUSINESSWIRE
24 Mar 2022
Share Share